{"schema_version":"1","generated_at":"2026-10-31T21:58:24.142Z","data_as_of":null,"url":"https://www.findmykol.com/kol/beverly-biller","json_url":"https://www.findmykol.com/kol/beverly-biller/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"beverly-biller","name":"Beverly Biller","credential":"MD","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"institution":"Harvard University","institution_url":"https://www.findmykol.com/institution/harvard-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1295726479","orcid":"0000-0003-4359-4622","openalex":"A5076292783"},"summary":"Beverly Biller is an Endocrinology/Metabolic physician affiliated with Harvard University. OpenAlex indexes 515 publications with 25,258 citations (h-index 80); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":515,"cited_by_count":25258,"h_index":80,"latest_activity_year":2025,"citation_standing":{"top_percent":5,"cohort":"Endocrinology, Diabetes & Metabolism","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00448747","title":"Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"AEterna Zentaris","source_url":"https://clinicaltrials.gov/study/NCT00448747","trial_url":"https://www.findmykol.com/trial/NCT00448747"}],"source":"trials"},"payments":{"company_count":15,"program_years":{"first":2021,"last":null},"rows_total":30,"shown":3,"withheld":27,"rows":[{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2025,"amount_usd":18365.49,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295726479"},{"payer":"Novo Nordisk Health Care AG","program_year":2025,"amount_usd":15002.72,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295726479"},{"payer":"RECORDATI_RARE_DISEASES_INC.","program_year":2025,"amount_usd":11443.58,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295726479"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1295726479","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Hormonal (systemic)","share_pct":50.6,"classes_total":2,"classes":[{"class":"l-Thyroxine","setting":"prescribed","share_pct":26.4,"drugs":[{"name":"Levothyroxine Sodium","share_pct":100}],"max_beneficiaries":12},{"class":"Recombinant Human Growth Hormone","setting":"prescribed","share_pct":24.1,"drugs":[{"name":"Genotropin","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":27.6,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":27.6,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Genitourinary & hormones","share_pct":21.8,"classes_total":1,"classes":[{"class":"Androgen","setting":"prescribed","share_pct":21.8,"drugs":[{"name":"Testosterone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":1989,"last":1999},"rows_total":5,"shown":3,"withheld":2,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"M01RR001066","title":"PHYSIOLOGIC EFFECTS OF LONG TERM GROWTH HORMONE IN ACQUIRED GH DEFICIENCY","fiscal_year":1999,"organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/M01RR001066"},{"project":"M01RR001066","title":"PHYSIOLOGIC EFFECTS OF LONG TERM GROWTH HORMONE IN ACQUIRED GH DEFICIENCY","fiscal_year":1998,"organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/M01RR001066"},{"project":"M01RR001066","title":"PHYSIOLOGIC EFFECTS OF LONG TERM GROWTH HORMONE IN GH DEFICIENCY.","fiscal_year":1997,"organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/M01RR001066"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","year":2023,"journal":"Nature Reviews Endocrinology","source_url":"https://doi.org/10.1038/s41574-023-00886-5","status":"verified"},{"title":"Multidisciplinary management of acromegaly: A consensus","year":2020,"journal":"Reviews in Endocrine and Metabolic Disorders","source_url":"https://doi.org/10.1007/s11154-020-09588-z","status":"verified"},{"title":"A Pituitary Society update to acromegaly management guidelines","year":2020,"journal":"Pituitary","source_url":"https://doi.org/10.1007/s11102-020-01091-7","status":"verified"},{"title":"Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","year":2020,"journal":"The Lancet Diabetes & Endocrinology","source_url":"https://doi.org/10.1016/s2213-8587(20)30240-0","status":"verified"},{"title":"A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update","year":2019,"journal":"The Journal of Clinical Endocrinology & Metabolism","source_url":"https://doi.org/10.1210/clinem/dgz096","status":"verified"}],"source":"works"},"contact":{"address_1":"ZERO EMERSON PLACE","address_2":"NEUROENDOCRINE SUITE 112EO 112","city":"Boston","state":"MA","zip":"02114","phone":"617-726-7948","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1295726479","source":"identity"},"similar":[{"name":"Thoralf Sundt","slug":"thoralf-sundt","institution":"Harvard University","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/thoralf-sundt","json_url":"https://www.findmykol.com/kol/thoralf-sundt/profile.json"},{"name":"Felipe Fregni","slug":"felipe-fregni","institution":"Harvard University","specialty":"Neurology","url":"https://www.findmykol.com/kol/felipe-fregni","json_url":"https://www.findmykol.com/kol/felipe-fregni/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Sarah Fortune","slug":"sarah-fortune","institution":"Harvard University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/sarah-fortune","json_url":"https://www.findmykol.com/kol/sarah-fortune/profile.json"},{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":27,"funding":2,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2009-09-01","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}